Our current focus is to bring our potential drugs to our patients. We are interested in drugs that can help patients “regain homeostasis.” In other words, we try to help our patients’ organ systems to keep cellular endoplasmic reticulum states stable. The challenge is that there are not many drugs that can modulate endoplasmic reticulum functions, but we have a few candidates as we recently published. We keep on working and keep you updated.
Thank you for reading this blog today. I had a lot of productive discussions last week. I am quite hopeful, and look forward to fruitful outcomes this week.